Rigense
Back to all news
GeopoliticsHigh impact

AnaptysBio quickly drops amid hearing on GSK/Tesaro contract breach

seekingalpha.com·21 hours ago·Unknown·1 min read
Rigense market context
Geopolitics
No image available. Showing a neutral Rigense placeholder.

AnaptysBio (ANAB) stock drops 8% as Delaware hearing with GSK/Tesaro over Jemperli contract breach unfolds.

Read original source

Related news